These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 22281156)

  • 21. Activity of IFN-gamma in experimental Leishmania infantum murine visceral leishmaniasis.
    Garin YJ; Sulahian A; Gangneux JP; Derouin F
    Pathol Biol (Paris); 1997 Jan; 45(1):48-51. PubMed ID: 9097846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leishmanicidal activity of an alkenylphenol from Piper malacophyllum is related to plasma membrane disruption.
    de Oliveira A; Mesquita JT; Tempone AG; Lago JH; Guimarães EF; Kato MJ
    Exp Parasitol; 2012 Nov; 132(3):383-7. PubMed ID: 22981719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo evaluation of anti-Leishmania activity of alkyltriazoles and alkylphosphocholines by oral route.
    Gontijo VS; Colombo FA; Ferreira Espuri P; Freitas PG; Nunes JB; Alves LB; Veloso MP; Alves RB; Freitas RP; Marques MJ
    Exp Parasitol; 2021; 226-227():108123. PubMed ID: 34144040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro effect of Aloe vera, Coriandrum sativum and Ricinus communis fractions on Leishmania infantum and on murine monocytic cells.
    Rondon FC; Bevilaqua CM; Accioly MP; Morais SM; Andrade-Junior HF; Machado LK; Cardoso RP; Almeida CA; Queiroz-Junior EM; Rodrigues AC
    Vet Parasitol; 2011 Jun; 178(3-4):235-40. PubMed ID: 21320755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
    Borborema SE; Schwendener RA; Osso JA; de Andrade HF; do Nascimento N
    Int J Antimicrob Agents; 2011 Oct; 38(4):341-7. PubMed ID: 21783345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
    Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
    de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
    Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum.
    Monteiro LM; Löbenberg R; Barbosa EJ; de Araujo GLB; Sato PK; Kanashiro E; de Araujo Eliodoro RH; Rocha M; de Freitas VLT; Fotaki N; Bou-Chacra NA
    Eur J Pharm Sci; 2022 Feb; 169():106097. PubMed ID: 34910988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
    Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
    Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone.
    Mäntylä A; Garnier T; Rautio J; Nevalainen T; Vepsälainen J; Koskinen A; Croft SL; Järvinen T
    J Med Chem; 2004 Jan; 47(1):188-95. PubMed ID: 14695832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leishmania chagasi: cytotoxic effect of infected macrophages on parenchymal liver cells.
    Dias Costa J; de Nazareth Meirelles M; Eduardo Pereira Velloso C; Porrozzi R
    Exp Parasitol; 2007 Dec; 117(4):390-8. PubMed ID: 17719578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproliferative and ultrastructural effects of phenethylamine derivatives on promastigotes and amastigotes of Leishmania (Leishmania) infantum chagasi.
    Brasil PF; de Freitas JA; Barreto ALS; Adade CM; Reis de Sá LF; Constantino-Teles P; Toledo FT; de Sousa BA; Gonçalves AC; Romanos MTV; Comasseto JV; Dos Santos AA; Tessis AC; Souto-Padrón T; Soares RMA; Ferreira-Pereira A
    Parasitol Int; 2017 Apr; 66(2):47-55. PubMed ID: 27888011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting of piperine intercalated in mannose-coated liposomes in experimental leishmaniasis.
    Raay B; Medda S; Mukhopadhyay S; Basu MK
    Indian J Biochem Biophys; 1999 Aug; 36(4):248-51. PubMed ID: 10650726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis.
    Romanelli MM; da Costa-Silva TA; Cunha-Junior E; Dias Ferreira D; Guerra JM; Galisteo AJ; Pinto EG; Barbosa LRS; Torres-Santos EC; Tempone AG
    Front Cell Infect Microbiol; 2019; 9():353. PubMed ID: 31737574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative.
    de Almeida L; Passalacqua TG; Dutra LA; Fonseca JNVD; Nascimento RFQ; Imamura KB; de Andrade CR; Dos Santos JL; Graminha MAS
    Biomed Pharmacother; 2017 Nov; 95():536-547. PubMed ID: 28866421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leishmania donovani: pilot study for evaluation of therapeutic effects of inosine analogs against amastigotes in vitro and in vivo.
    Morishige K; Aji T; Ishii A; Yasuda T; Wataya Y
    Exp Parasitol; 1995 Jun; 80(4):665-71. PubMed ID: 7758547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis.
    Lalatsa A; Statts L; Adriana de Jesus J; Adewusi O; Auxiliadora Dea-Ayuela M; Bolas-Fernandez F; Dalastra Laurenti M; Felipe Domingues Passero L; Serrano DR
    Int J Pharm; 2020 Oct; 588():119734. PubMed ID: 32777535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis.
    Rodrigues RF; Charret KS; Campos MC; Amaral V; Echevarria A; Dos Reis C; Canto-Cavalheiro MM; Leon LL
    J Antimicrob Chemother; 2012 Jan; 67(1):182-90. PubMed ID: 21987238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of nitro-heterocyclic derivatives against Leishmania (Leishmania) infantum promastigotes and intracellular amastigotes.
    Petri e Silva SC; Palace-Berl F; Tavares LC; Soares SR; Lindoso JA
    Exp Parasitol; 2016 Apr; 163():68-75. PubMed ID: 26795261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.